Follow-The-Filings

DRUG Bright Minds Biosciences

Bright Minds Biosciences earnings company data as of 7:18 PM ET 8/21

  • 1 of 1 EPS beats

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS -1.64 -0.24 Beat
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K Period May 26, 2026
6-K FORM 6-K
6-K FORM 6-K
424B5 FORM 424B5
6-K FORM 6-K
6-K FORM 6-K
6-K Period Jan 7, 2026
6-K Period Jan 6, 2026
424B5 FORM 424B5
6-K FORM 6-K
6-K Period Jan 6, 2026
6-K Period Jan 5, 2026
6-K/A FORM 6-K/A
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K Period Sep 4, 2025
6-K FORM 6-K
6-K FORM 6-K
6-K Period May 28, 2025
6-K Period May 20, 2025
6-K Period May 13, 2025

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period Apr 28, 2026
4 Period Nov 4, 2024

Consensus estimates · SEC filings remain the official record · not investment advice